R&D Expenses

$1.63B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN R&D Expenses

Latest reported$1.63Bperiod endingJun 30, 2026

REGN Quarterly R&D Expenses ($0.00 → $1.63B)

Quarterly R&D Expenses

High-resolution chart · PNG

REGN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	1,631,600,000
Mar 31, 2026	1,645,400,000
Dec 31, 2025	1,626,100,000
Sep 30, 2025	1,558,100,000
Jun 30, 2025	1,431,700,000
Mar 31, 2025	1,339,700,000
Dec 31, 2024	1,425,900,000
Sep 30, 2024	1,327,700,000
Jun 30, 2024	1,223,900,000
Mar 31, 2024	1,255,500,000
Dec 31, 2023	1,050,599,999
Sep 30, 2023	969,900,000
Jun 30, 2023	982,200,000
Mar 31, 2023	1,001,700,000
Dec 31, 2022	941,600,000
Sep 30, 2022	818,700,000
Jun 30, 2022	719,900,000
Mar 31, 2022	769,500,000
Dec 31, 2021	711,100,000
Sep 30, 2021	592,200,000
Jun 30, 2021	643,100,000
Mar 31, 2021	675,500,000
Dec 31, 2020	682,800,000
Sep 30, 2020	625,300,000
Jun 30, 2020	663,200,000
Mar 31, 2020	527,799,999
Dec 31, 2019	683,100,000
Sep 30, 2019	473,100,000
Jun 30, 2019	833,400,000
Mar 31, 2019	435,100,000
Dec 31, 2018	558,441,000
Sep 30, 2018	521,530,999
Jun 30, 2018	495,647,000
Mar 31, 2018	462,228,000
Dec 31, 2017	493,476,000
Sep 30, 2017	492,030,000
Jun 30, 2017	474,849,000
Mar 31, 2017	469,320,000
Dec 31, 2016	450,306,000
Sep 30, 2016	515,207,999
Jun 30, 2016	559,930,000
Mar 31, 2016	470,112,000
Dec 31, 2015	461,210,000
Sep 30, 2015	425,924,000
Jun 30, 2015	390,330,000
Mar 31, 2015	343,113,000
Dec 31, 2014	351,745,000
Sep 30, 2014	337,728,000
Jun 30, 2014	294,501,000
Mar 31, 2014	287,379,000
Dec 31, 2013	268,140,000
Sep 30, 2013	224,045,000
Jun 30, 2013	187,463,000
Mar 31, 2013	180,299,000
Dec 31, 2012	181,024,000
Sep 30, 2012	158,295,000
Jun 30, 2012	147,373,000
Mar 31, 2012	138,862,000
Dec 31, 2011	129,041,000
Sep 30, 2011	127,924,000
Jun 30, 2011	143,149,000
Mar 31, 2011	129,392,000
Dec 31, 2010	125,212,000
Sep 30, 2010	122,043,000
Jun 30, 2010	124,526,000
Mar 31, 2010	117,471,000
Dec 31, 2009	118,790,000
Sep 30, 2009	105,434,000
Jun 30, 2009	94,231,000
Mar 31, 2009	82,146,000
Dec 31, 2008	76,314,000
Sep 30, 2008	73,855,000
Jun 30, 2008	66,577,000
Mar 31, 2008	61,270,000
Dec 31, 2007	64,825,000
Sep 30, 2007	51,689,000
Jun 30, 2007	43,864,000
Mar 31, 2007	41,235,000
Dec 31, 2006	35,774,000
Sep 30, 2006	34,808,000
Jun 30, 2006	34,398,000
Mar 31, 2006	32,084,000
Dec 31, 2005	37,911,000
Sep 30, 2005	41,116,000
Jun 30, 2005	40,642,000
Mar 31, 2005	35,912,000
Dec 31, 2004	34,789,000
Sep 30, 2004	32,828,000
Jun 30, 2004	36,297,000
Mar 31, 2004	32,181,000
Dec 31, 2003	33,267,000
Sep 30, 2003	34,650,000
Jun 30, 2003	33,717,000
Mar 31, 2003	34,390,000
Dec 31, 2002	34,455,000
Sep 30, 2002	34,294,000
Jun 30, 2002	30,702,000
Mar 31, 2002	25,475,000
Dec 31, 2001	30,100,000
Sep 30, 2001	25,039,000